Đang chuẩn bị liên kết để tải về tài liệu:
Prevalence and burden of illness of treated hemolytic neonatal hyperbilirubinemia in a privately insured population in the United States

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Prevalence of hemolytic neonatal hyperbilirubinemia (NHB) is not well characterized, and economic burden at the population level is poorly understood. This study evaluated the prevalence, clinical characteristics, and economic burden of hemolytic NHB newborns receiving treatment in U.S. real-world settings. | Prevalence and burden of illness of treated hemolytic neonatal hyperbilirubinemia in a privately insured population in the United States

TÀI LIỆU LIÊN QUAN

Total and partial cancer prevalence in the adult French population in 2008

Bacteriological profile of hospital acquired infections with multidrug resistance burden and extended spectrum Beta lactamase prevalence

The economic burden of bronchiectasis – known and unknown: A systematic review

Health and Quality of Life Outcomes BioMed Central Research Open Access Prevalence and burden of

CGFS Papers : Financial stability and local currency bond markets

The impact of sovereign credit risk on bank funding conditions

PROGRESS IN FINANCIAL SERVICES RISK MANAGEMENT: A SURVEY OF MAJOR FINANCIAL INSTITUTIONS

PREVENTION AND CONTROL OF AIR POLLUTION BY PROCESS CHANGES OR EQUIPMENT

Chitkara Business School Presents International Conference Contemporary Issues in Business 2013

CSD-14 National Reporting Guidelines: ATMOSPHERE/AIR POLLUTION
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.